HomeRNAZ • NASDAQ
add
Transcode Therapeutics Inc
Previous close
$8.67
Day range
$8.34 - $8.52
Year range
$6.08 - $22.03
Market cap
7.81M USD
Avg Volume
7.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.24M | 42.16% |
Net income | -13.44M | -127.23% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.19M | -41.57% |
Effective tax rate | -1.71% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.81M | 206.54% |
Total assets | 162.40M | 2,126.32% |
Total liabilities | 10.52M | 12.94% |
Total equity | 151.88M | — |
Shares outstanding | 916.97K | — |
Price to book | 0.77 | — |
Return on assets | -21.59% | — |
Return on capital | -23.61% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -13.44M | -127.23% |
Cash from operations | -8.14M | -158.78% |
Cash from investing | -4.44K | -787.20% |
Cash from financing | 23.12M | 226.52% |
Net change in cash | 14.98M | 280.61% |
Free cash flow | -6.15M | -235.13% |
About
Founded
2016
Headquarters
Website
Employees
12
